ArticleJournal for immunotherapy of cancer2021

Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma.

Amani Makkouk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.